医学
腹主动脉
腹主动脉瘤
胸主动脉
主动脉
血管紧张素II
主动脉瘤
心脏病学
动脉瘤
内科学
动脉瘤
肿瘤坏死因子α
外科
病理
放射科
血压
作者
David Carmona-Berrio,Isabel Adarve-Rengifo,Andrea G. Marshall,Zer Vue,Duane D. Hall,Tyne W. Miller‐Fleming,Ky’Era V. Actkins,Heather K. Beasley,Paula Almonacid,Pierina Barturen‐Larrea,Quinn S. Wells,Marcos G. Lopez,Edgar Garza-López,Dao‐Fu Dai,Jianqiang Shao,Kit Neikirk,Frederic T. Billings,John A. Curci,Nancy J. Cox,Vivian Gama
出处
期刊:iScience
[Cell Press]
日期:2024-07-24
卷期号:27 (9): 110436-110436
标识
DOI:10.1016/j.isci.2024.110436
摘要
Abdominal and thoracic aortic aneurysms (AAAs, TAAs) remain a major cause of deaths worldwide, in part due to the lack of reliable prognostic markers or early warning signs. Sox6 has been found to regulate renin controlling blood pressure. We hypothesized that Sox6 may serve as an important regulator of the mechanisms contributing to hypertension-induced aortic aneurysms. Phenotype and laboratory-wide association scans in a clinical cohort found that SOX6 gene expression is associated with aortic aneurysm in subjects of European ancestry. Sox6 and tumor necrosis factor alpha (TNF-α) expression were upregulated in aortic tissues from patients affected by either AAA or TAA. In Sox6 knockout mice with angiotensin-II-induced AAA, we found that Sox6 plays critical role in the development and progression of AAA. Our data support a regulatory role of SOX6 in the development of hypertension-induced AAA, suggesting that Sox6 may be a therapeutic target for the treatment of aortic aneurysms.
科研通智能强力驱动
Strongly Powered by AbleSci AI